China Health Industries Holdings CHHE · USD
Consumer Staples · US listing · 🇺🇸 United States
0.00
—
Close of 30 Oct 2026, in USD
About China Health Industries Holdings
Its shares trade under the ticker CHHE. It has been listed since 1 December 2004. In the fiscal year to 30 June 2023, it reported revenue of $111,579 and a net loss of $409,000. At that date it held total assets of $45.1m and shareholders' equity of $39.1m.
China Health Industries Holdings, Inc. engages in the production and distribution of medicines, health products, health devices, and cosmetics. The company is headquartered in Harbin, Heilongjiang. The company went IPO on 2004-12-01. The firm's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The firm has three operating segments: Humankind, HLJ Huimeijia and others. Humankind is engaged in the manufacturing and sale of health products. HLJ Huimeijia is engaged in the manufacturing and distribution of tincture; ointments; rubber paste, including hormones; topical solution, suppositories, liniment, including traditional Chinese medicine extractions; enemas, and oral liquids. As of June 30, 2016, the Company, through Humankind manufactured and sold 14 health supplement products. As of June 30, 2016, the Company, through HLJ Huimeijia manufactured and sold 21 products. The firm's products are sold through sales agents.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Products
- Listed since
- 1 Dec 2004
- Employees
- 112
- Website
- chinahealthindustries.com ↗
Leadership
Pay as last reported
- Mr. Xin SunChairman of the Board, Chief Executive Officer, Chief Financial Officer, Treasurer, since 2007$12,523
- Mr. Baosen MaPresident, Secretary, Director, since 2004
- Mr. Kai SunDirector
- Ms. Melody ZhangInvestor Relations
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- China Health Industries Holdings Inc has several strengths that contribute to its success in the health industry market. Firstly, the company has a strong brand reputation and extensive market experience, which enhances its credibility and customer trust. Additionally, China Health Industries has a wide range of products and services, providing customers with various options for their healthcare needs.
- Furthermore, the company has established a solid distribution network, enabling efficient product delivery and wider market reach. China Health Industries also benefits from its strong relationships with suppliers and business partners, ensuring a reliable supply chain and potential collaboration opportunities.
Weaknesses
- Despite its strengths, China Health Industries Holdings Inc also faces certain weaknesses that could hinder its growth and competitive advantage. One weakness is the lack of global presence and dependence on the Chinese market, which exposes the company to potential market fluctuations and regulatory challenges within the country.
- Another weakness is the company's limited technological advancements compared to some competitors. This could hinder innovation and product development, affecting its ability to adapt to changing customer preferences and market trends. Additionally, the company may face challenges in attracting and retaining top talent, especially in a highly competitive industry.
Opportunities
- Several opportunities exist for China Health Industries Holdings Inc to capitalize on and further expand its business. One opportunity is the growing demand for healthcare products and services in China, driven by an aging population and increasing health awareness. The company can leverage this demand to introduce new products and services, capturing a larger market share.
- Another opportunity lies in international expansion. By exploring new markets outside of China, such as emerging economies with rising healthcare needs, China Health Industries can diversify its revenue sources and minimize dependence on a single market. Furthermore, advancements in technology present opportunities for the company to invest in research and development, potentially leading to innovative healthcare solutions and increased competitiveness.
Threats
- China Health Industries Holdings Inc faces certain threats that could impact its growth and profitability. One major threat is increasing competition within the health industry, both from domestic and international players. This competition could result in price pressures, market saturation, and the need for continuous differentiation to stand out.
- Economic and political uncertainties in China also pose threats to the company's operations. Fluctuations in the Chinese economy, changes in government regulations, and geopolitical factors can significantly impact the business environment and disrupt market conditions. Lastly, potential health crises or epidemics could endanger the company's operations and create uncertainties in demand and supply chains.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.